Health Care

Diabetics in U.S. May Double in 25 Years Tripling Health Cost, Report Says The number of Americans with diabetes may almost double in 25 years, and the annual cost of treating them may triple to $336 billion, according to a study published today in the journal Diabetes Care.

Bayer Taps Marijn Dekkers for Portfolio, Deal-Making Skills, Wenning Says Bayer AG Chief Executive Officer Werner Wenning knew the German drug and chemical maker’s search for his replacement was over the day he met Marijn Dekkers.

Siemens Hearing Aids Business Said to Draw Interest From Private Equity Siemens AG’s hearing aid business, valued at as much as 3 billion euros ($4.5 billion), is drawing interest from private-equity firms including KKR & Co. L.P. and BC Partners Ltd., two people familiar with the matter said.

Ranbaxy Laboratories Shares Gain After Starting Sales of Valtrex in U.S. Ranbaxy Laboratories Ltd. rose as much as 3.7 percent in Mumbai and traded at 439.9 rupees as of 10:10 a.m. local time. India’s biggest drugmaker said it has begun selling a generic version of GlaxoSmithKline Plc’s Valtrex drug in the U.S.

Greenhouse-Gas Pledges by China, U.S. May Drive Climate Deal in Copenhagen Pledges by China and the U.S. to set numerical targets for their greenhouse-gas emissions through 2020 may reignite stalled progress for a global climate agreement at negotiations next month in Copenhagen.

Ayrton Says Adcock Ingram to Acquire 51% of Company to Lift African Sales Ayrton Drug Manufacturing Ltd., a Ghanaian pharmaceuticals maker, said it approved Adcock Ingram Holdings Ltd.’s bid for the company.

EU Confirms It Sent Complaints to Companies in Cathode-Ray Tube Industry European Union regulators sent complaints to Royal Philips Electronics NV and other companies in the cathode-ray tube industry following an antitrust investigation.